
Eli Lilly Sues Six Retatrutide Sellers | What the August 2026 Filings Mean for Peptide Companies, Clinics, and Compounding Pharmacies
Eli Lilly sued six retatrutide sellers and says it referred over 200 more to FDA and DOJ. What peptide vendors, clinics, and pharmacies should do right now.












